{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T03:48:12Z","timestamp":1783741692217,"version":"3.55.0"},"reference-count":68,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2022,5,2]],"date-time":"2022-05-02T00:00:00Z","timestamp":1651449600000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008893","name":"University of Iowa","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008893","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,5,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:label\/>\n                  <jats:p>Studies demonstrated the impact of the COVID-19 pandemic in the prevalence and susceptibility profiles of bacterial and fungal organisms. We analyzed 4821 invasive fungal isolates collected during 2018, 2019, and 2020 in 48 hospitals worldwide to evaluate the impact of this event in the occurrence and susceptibility rates of common fungal species. Isolates were tested using the CLSI broth microdilution method. While the percentage of total isolates that were C. glabrata (n = 710 isolates) or C. krusei (n = 112) slightly increased in 2020, the percentage for C. parapsilosis (n = 542), A. fumigatus (n = 416), and C. lusitaniae (n = 84) significantly decreased (P &amp;lt; .05). Fluconazole resistance in C. glabrata decreased from 5.8% in 2018\u20132019 to 2.0% in 2020, mainly due to fewer hospitals in the US having these isolates (5 vs. 1 hospital). Conversely, higher fluconazole-resistance rates were noted for C. parapsilosis (13.9 vs. 9.8%) and C. tropicalis (3.5 vs. 0.7%; P &amp;lt; .05) during 2020. Voriconazole resistance also increased for these species. Echinocandin resistance was unchanged among Candida spp. Voriconazole susceptibility rates in A. fumigatus were similar in these two periods (91.7% in 2018 and 2019 vs. 93.0% in 2020). Changes were also noticed in the organisms with smaller numbers of collected isolates. We observed variations in the occurrence of organisms submitted to a global surveillance and the susceptibility patterns for some organism-antifungal combinations. As the COVID-19 pandemic is still ongoing, the impact of this event must continue to be monitored to guide treatment of patients affected by bacterial and fungal infections.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Lay Summary<\/jats:title>\n                  <jats:p>Secondary infections were documented in COVID-19 patients. We compared the prevalence of invasive fungal isolates consecutively collected in 48 worldwide hospitals and their susceptibility patterns between 2020, the year of the global COVID-19 pandemic, and the two prior years.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/mmy\/myac028","type":"journal-article","created":{"date-parts":[[2022,4,14]],"date-time":"2022-04-14T11:11:25Z","timestamp":1649934685000},"source":"Crossref","is-referenced-by-count":25,"title":["Impact of COVID-19 on the antifungal susceptibility profiles of isolates collected in a global surveillance program that monitors invasive fungal infections"],"prefix":"10.1093","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4501-6068","authenticated-orcid":false,"given":"Michael A","family":"Pfaller","sequence":"first","affiliation":[{"name":"JMI Laboratories, North Liberty, IA 52317"},{"name":"Department of Pathology, University of Iowa, Iowa City, IA 52242, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2734-3754","authenticated-orcid":false,"given":"Cecilia G","family":"Carvalhaes","sequence":"additional","affiliation":[{"name":"JMI Laboratories, North Liberty, IA 52317"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6902-9763","authenticated-orcid":false,"given":"Sean","family":"DeVries","sequence":"additional","affiliation":[{"name":"JMI Laboratories, North Liberty, IA 52317"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6798-7653","authenticated-orcid":false,"given":"Paul R","family":"Rhomberg","sequence":"additional","affiliation":[{"name":"JMI Laboratories, North Liberty, IA 52317"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0126-1782","authenticated-orcid":false,"given":"Mariana","family":"Castanheira","sequence":"additional","affiliation":[{"name":"JMI Laboratories, North Liberty, IA 52317"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,5,2]]},"reference":[{"key":"2022050616242319400_bib1","doi-asserted-by":"crossref","first-page":"e206","DOI":"10.1093\/cid\/ciaa1012","article-title":"Risk factors for intensive care unit admission and in-hospital mortality among hospitalized adults identified through the US Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET)","volume":"72","author":"Kim","year":"2021","journal-title":"Clin Infect Dis."},{"key":"2022050616242319400_bib2","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1038\/s41564-020-0739-4","article-title":"Antimicrobial resistance in the age of COVID-19","volume":"5","author":"Anonymous","year":"2020","journal-title":"Nat Microbiol."},{"key":"2022050616242319400_bib3","first-page":"29","article-title":"Bacterial and fungal infections among patients with SARS-CoV-2 pneumonia","volume":"28","author":"Antinori","year":"2020","journal-title":"Le infezioni in medicina : rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive."},{"key":"2022050616242319400_bib4","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1007\/s00134-020-06219-8","article-title":"Bacterial and fungal superinfections in critically ill patients with COVID-19","volume":"46","author":"Bassetti","year":"2020","journal-title":"Intensive Care Med."},{"key":"2022050616242319400_bib5","doi-asserted-by":"crossref","first-page":"4358","DOI":"10.3390\/ijerph18084358","article-title":"Co-infections in critically ill patients with or without COVID-19: a comparison of clinical microbial culture findings","volume":"18","author":"Cultrera","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"2022050616242319400_bib6","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.jiph.2021.02.011","article-title":"Antimicrobial resistance threats in the emerging COVID-19 pandemic: where do we stand?","volume":"14","author":"Ghosh","year":"2021","journal-title":"J Infection Public Health"},{"key":"2022050616242319400_bib7","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.cmi.2020.06.025","article-title":"Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary-care setting","volume":"26","author":"Hughes","year":"2020","journal-title":"Clin Microbiol Infect."},{"key":"2022050616242319400_bib8","doi-asserted-by":"crossref","first-page":"145","DOI":"10.5858\/arpa.2020-0284-RA","article-title":"Geospatial spread of antimicrobial resistance, bacterial and fungal threats to Coronavirus Infectious Disease 2019 (COVID-19) survival, and point-of-care solutions","volume":"145","author":"Kost","year":"2021","journal-title":"Arch Pathol Lab Med."},{"key":"2022050616242319400_bib9","doi-asserted-by":"crossref","first-page":"ofab201","DOI":"10.1093\/ofid\/ofab201","article-title":"Characterization of bacterial and fungal infections in hospitalized patients with Coronavirus Disease 2019 and factors associated with health care-associated infections","volume":"8","author":"Kubin","year":"2021","journal-title":"Open Forum Infect Dis."},{"key":"2022050616242319400_bib10","doi-asserted-by":"crossref","first-page":"e0251170","DOI":"10.1371\/journal.pone.0251170","article-title":"Prevalence and outcomes of co-infection and superinfection with SARS-CoV-2 and other pathogens: a systematic review and meta-analysis","volume":"16","author":"Musuuza","year":"2021","journal-title":"PLoS One."},{"key":"2022050616242319400_bib11","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.3390\/jcm10081752","article-title":"Risk factors for mortality in adult COVID-19 patients who develop bloodstream infections mostly caused by antimicrobial-resistant organisms: analysis at a large teaching hospital in Italy","volume":"10","author":"Posteraro","year":"2021","journal-title":"J Clin Med."},{"key":"2022050616242319400_bib12","first-page":"2459","article-title":"Bacterial and fungal coinfection in individuals with Coronavirus: a rapid review to support COVID-19 antimicrobial prescribing","volume":"71","author":"Rawson","year":"2020","journal-title":"Clin Infect Dis."},{"key":"2022050616242319400_bib13","doi-asserted-by":"crossref","first-page":"e533","DOI":"10.1093\/cid\/ciaa1239","article-title":"Empiric antibacterial therapy and community-onset bacterial coinfection in patients hospitalized with Coronavirus Disease 2019 (COVID-19): a multi-hospital cohort study","volume":"72","author":"Vaughn","year":"2021","journal-title":"Clin Infect Dis."},{"key":"2022050616242319400_bib14","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1080\/22221751.2020.1812437","article-title":"Risks and features of secondary infections in severe and critical ill COVID-19 patients","volume":"9","author":"Zhang","year":"2020","journal-title":"Emerg Microbes Infect."},{"key":"2022050616242319400_bib15","doi-asserted-by":"crossref","first-page":"ofab065","DOI":"10.1093\/ofid\/ofab065","article-title":"Bacterial superinfections among persons with Coronavirus Disease 2019: a comprehensive review of data from postmortem studies","volume":"8","author":"Clancy","year":"2021","journal-title":"Open Forum Infect Dis"},{"key":"2022050616242319400_bib16","first-page":"359","article-title":"Bacterial coinfections in COVID-19: an underestimated adversary","volume":"56","author":"Fattorini","year":"2020","journal-title":"Ann Ist Super Sanita."},{"key":"2022050616242319400_bib17","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3390\/jof6020091","article-title":"COVID-19 associated pulmonary Aspergillosis (CAPA)-from immunology to treatment","volume":"6","author":"Arastehfar","year":"2020","journal-title":"J Fungi (Basel)."},{"key":"2022050616242319400_bib18","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3390\/jof6040211","article-title":"COVID-19-associated Candidiasis (CAC): an underestimated complication in the absence of immunological predispositions?","volume":"6","author":"Arastehfar","year":"2020","journal-title":"J Fungi (Basel)."},{"key":"2022050616242319400_bib19","doi-asserted-by":"crossref","first-page":"100971","DOI":"10.1016\/j.mycmed.2020.100971","article-title":"Invasive fungal diseases during COVID-19: we should be prepared","volume":"30","author":"Gangneux","year":"2020","journal-title":"J Mycol Med."},{"key":"2022050616242319400_bib20","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jmii.2020.09.004","article-title":"COVID-19 associated with pulmonary aspergillosis: a literature review","volume":"54","author":"Lai","year":"2021","journal-title":"J Microbiol Immunol Infect."},{"key":"2022050616242319400_bib21","first-page":"18","article-title":"Aspergillosis complicating severe coronavirus disease","volume-title":"Emerg Infect Dis.","author":"Marr","year":"2021"},{"key":"2022050616242319400_bib22","first-page":"ciaa1594","article-title":"Candidemia in COVID-19 patients: incidence and characteristics in a prospective cohort compared to historical non-COVID-19 controls","author":"Mastrangelo","year":"2020","journal-title":"Clin Infect Dis."},{"key":"2022050616242319400_bib23","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.ajic.2020.11.015","article-title":"Fungal superinfection in patients with COVID-19: role of antifungal stewardship?","volume":"49","author":"Nestler","year":"2021","journal-title":"Am J Infect Control."},{"key":"2022050616242319400_bib24","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/myc.13225","article-title":"Increased incidence of candidemia in a tertiary care hospital with the COVID-19 pandemic","volume":"64","author":"Nucci","year":"2021","journal-title":"Mycoses."},{"key":"2022050616242319400_bib25","article-title":"The landscape of candidemia during the COVID-19 pandemic","volume-title":"Clin Infect Dis.","author":"Seagle","year":"2021"},{"key":"2022050616242319400_bib26","doi-asserted-by":"crossref","first-page":"102146","DOI":"10.1016\/j.dsx.2021.05.019","article-title":"Mucormycosis in COVID-19: a systematic review of cases reported worldwide and in India","volume":"15","author":"Singh","year":"2021","journal-title":"Diabetes Metab Syndr."},{"key":"2022050616242319400_bib27","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.2217\/fmb-2020-0156","article-title":"Systemic mycoses: a potential alert for complications in COVID-19 patients","volume":"15","author":"Segrelles-Calvo","year":"2020","journal-title":"Future Microbiol."},{"key":"2022050616242319400_bib28","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s11046-020-00462-9","article-title":"Fungal co-infections associated with global COVID-19 pandemic: a clinical and diagnostic perspective from China","volume":"185","author":"Song","year":"2020","journal-title":"Mycopathologia."},{"key":"2022050616242319400_bib29","article-title":"Candidaemia in COVID-19, a link to disease pathology or increased clinical pressures?","volume-title":"Clin Infect Dis.","author":"White","year":"2020"},{"key":"2022050616242319400_bib30","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.cmi.2020.07.041","article-title":"Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study","volume":"27","author":"Garcia-Vidal","year":"2021","journal-title":"Clin Microbiol Infect."},{"key":"2022050616242319400_bib31","first-page":"e48","article-title":"Prevalence of putative invasive pulmonary aspergillosis in critically ill patients with COVID-19","volume-title":"Lancet Respir Med.","author":"Alanio","year":"2020"},{"key":"2022050616242319400_bib32","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3390\/jof6020079","article-title":"Azole-resistant COVID-19-associated pulmonary Aspergillosis in an immunocompetent host: a case report","volume":"6","author":"Meijer","year":"2020","journal-title":"J Fungi (Basel)."},{"key":"2022050616242319400_bib33","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s11046-021-00528-2","article-title":"Coronavirus disease (Covid-19) associated Mucormycosis (CAM): case report and systematic review of literature","volume":"186","author":"Garg","year":"2021","journal-title":"Mycopathologia."},{"key":"2022050616242319400_bib34","first-page":"2349","article-title":"Multicenter epidemiologic study of Coronavirus disease-associated Mucormycosis, India","volume-title":"Emerg Infect Dis.","author":"Patel","year":"2021"},{"key":"2022050616242319400_bib35","doi-asserted-by":"crossref","first-page":"816","DOI":"10.3390\/antibiotics9110816","article-title":"Impact of the COVID-19 pandemic on antimicrobial consumption and hospital-acquired Candidemia and multidrug-resistant bloodstream infections","volume":"9","author":"Guisado-Gil","year":"2020","journal-title":"Antibiotics (Basel)."},{"key":"2022050616242319400_bib36","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.cmi.2020.12.030","article-title":"Outbreak of Candida auris infection in a COVID-19 hospital in Mexico","volume":"27","author":"Villanueva-Lozano","year":"2021","journal-title":"Clin Microbiol Infect."},{"key":"2022050616242319400_bib37","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.ijantimicag.2014.06.007","article-title":"Activity of echinocandins and triazoles against a contemporary (2012) worldwide collection of yeast and molds collected from invasive infections","volume":"44","author":"Castanheira","year":"2014","journal-title":"Int J Antimicrob Agents."},{"key":"2022050616242319400_bib38","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s11046-012-9551-x","article-title":"Significance of molecular identification and antifungal susceptibility of clinically significant yeasts and molds in a global antifungal surveillance program","volume":"174","author":"Pfaller","year":"2012","journal-title":"Mycopathologia."},{"key":"2022050616242319400_bib39","first-page":"219","article-title":"Invasive fungal infections and approaches to their diagnosis","volume-title":"Methods in Microbiology","author":"Pfaller","year":"2015"},{"key":"2022050616242319400_bib40","doi-asserted-by":"crossref","first-page":"e01230","DOI":"10.1128\/AAC.01230-18","article-title":"In vitro activity of isavuconazole versus opportunistic fungal pathogens from two mycology reference laboratories","volume":"62","author":"Pfaller","year":"2018","journal-title":"Antimicrob Agents Chemother."},{"key":"2022050616242319400_bib41","volume-title":"Reference method for broth dilution antifungal susceptbility testing of yeasts","author":"M27Ed4","year":"2017"},{"key":"2022050616242319400_bib42","volume-title":"Reference method for broth dilution antifungal susceptibilty testing of filamentous fungi, third edition","author":"M38Ed3","year":"2018"},{"key":"2022050616242319400_bib43","volume-title":"Epidemiological Cut-off values for antifungal susceptibility testing, third edition","author":"M59Ed3","year":"2020"},{"key":"2022050616242319400_bib44","volume-title":"Performance standards for antifungal susceptibility testing of yeasts","author":"M60Ed2","year":"2020"},{"key":"2022050616242319400_bib45","volume-title":"Performance standards for antifungal susceptibility testing of filamentous fungi, second edition","author":"M61Ed2","year":"2020"},{"key":"2022050616242319400_bib46","doi-asserted-by":"crossref","first-page":"e00906","DOI":"10.1128\/AAC.00906-17","article-title":"Monitoring antifungal resistance in a global collection of invasive yeasts and molds: application of CLSI epidemiological cut-off values and whole genome sequencing analysis for detection of azole resistance in Candida albicans","volume":"61","author":"Castanheira","year":"2017","journal-title":"Antimicrob Agents Chemother."},{"key":"2022050616242319400_bib47","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1111\/myc.13267","article-title":"Isavuconazole nonwild-type Aspergillus fumigatus isolates from a global surveillance study display alterations in multiple genes involved in the ergosterol biosynthesis pathway not previously associated with resistance to other azoles","volume":"64","author":"Castanheira","year":"2021","journal-title":"Mycoses"},{"key":"2022050616242319400_bib48","first-page":"779","article-title":"Antimicrobial resistance in the age of COVID-19","volume-title":"Nature Microbiol","author":"Anonymous","year":"2020"},{"key":"2022050616242319400_bib49","doi-asserted-by":"crossref","first-page":"e354","DOI":"10.1016\/S2666-5247(21)00090-2","article-title":"Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre, prospective cohort study","volume":"2","author":"Russell","year":"2021","journal-title":"Lancet Microbe"},{"key":"2022050616242319400_bib50","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3390\/jof6030163","article-title":"Pan-Echinocandin-resistant Candida glabrata bloodstream infection complicating COVID-19: a fatal case report","volume":"6","author":"Posteraro","year":"2020","journal-title":"J Fungi (Basel)"},{"key":"2022050616242319400_bib51","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1128\/CMR.00029-06","article-title":"Epidemiology of invasive candidiasis: a persistent public health problem","volume":"20","author":"Pfaller","year":"2007","journal-title":"Clin Microbiol Rev"},{"key":"2022050616242319400_bib52","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1093\/ofid\/ofy358","article-title":"Twenty years of the SENTRY Antifungal Surveillance Program: Results for Candida species From 1997-2016","volume":"6","author":"Pfaller","year":"2019","journal-title":"Open Forum Infect Dis."},{"key":"2022050616242319400_bib53","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1093\/cid\/cit136","article-title":"Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations","volume":"56","author":"Alexander","year":"2013","journal-title":"Clin Infect Dis."},{"key":"2022050616242319400_bib54","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1128\/CMR.00013-08","article-title":"Candida parapsilosis, an emerging fungal pathogen","volume":"21","author":"Trofa","year":"2008","journal-title":"Clin Microbiol Rev."},{"key":"2022050616242319400_bib55","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1128\/CMR.12.1.80","article-title":"Candida glabrata: Review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans","volume":"12","author":"Fidel","year":"1999","journal-title":"Clin Microbiol Rev."},{"key":"2022050616242319400_bib56","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1093\/cid\/civ1194","article-title":"Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America","volume":"62","author":"Pappas","year":"2016","journal-title":"Clin Infect Dis."},{"key":"2022050616242319400_bib57","doi-asserted-by":"crossref","first-page":"4419","DOI":"10.1128\/JCM.42.10.4419-4431.2004","article-title":"Rare and emerging opportunistic fungal pathogens: concern for resistance beyond Candida albicans and Aspergillus fumigatus","volume":"42","author":"Pfaller","year":"2004","journal-title":"J Clin Microbiol."},{"key":"2022050616242319400_bib58","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1093\/jac\/dkq136","article-title":"Candidaemia associated with decreased in vitro fluconazole susceptibility: Is Candida speciation predictive of the susceptibility pattern?","volume":"65","author":"Oxman","year":"2010","journal-title":"J Antimicrob Chemother."},{"key":"2022050616242319400_bib59","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.3389\/fmicb.2017.01927","article-title":"An update on Candida tropicalis based on basic and clinical approaches","volume":"8","author":"Zuza-Alves","year":"2017","journal-title":"Front Microbiol."},{"key":"2022050616242319400_bib60","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3390\/jof2030021","article-title":"Triazole resistance in Aspergillus spp.: a worldwide problem?","volume":"2","author":"Rivero-Menendez","year":"2016","journal-title":"J Fungi (Basel)."},{"key":"2022050616242319400_bib61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.aambs.2019.10.003","article-title":"Detection of the \u2018big five\u2019 mold killers of humans: Aspergillus, Fusarium, Lomentospora, Scedosporium and Mucormycetes","volume":"110","author":"Thornton","year":"2020","journal-title":"Adv Appl Microbiol."},{"key":"2022050616242319400_bib62","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/cid\/civ885","article-title":"Azole resistance in Aspergillus fumigatus: can we retain the clinical use of mold-active antifungal azoles?","volume":"62","author":"Verweij","year":"2016","journal-title":"Clin Infect Dis."},{"key":"2022050616242319400_bib63","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3390\/jof4040129","article-title":"Antifungal resistance: specific focus on multidrug resistance in Candida auris and secondary azole resistance in Aspergillus fumigatus","volume":"4","author":"Arikan-Akdagli","year":"2018","journal-title":"J Fungi (Basel)."},{"key":"2022050616242319400_bib64","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1093\/jac\/dkq279","article-title":"Azole antifungal resistance in Aspergillus fumigatus: 2008 and 2009","volume":"65","author":"Bueid","year":"2010","journal-title":"J Antimicrob Chemother."},{"key":"2022050616242319400_bib65","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1007\/s10096-015-2374-1","article-title":"Unpredictable susceptibility of emerging clinical molds to tri-azoles: review of the literature and upcoming challenges for mold identification","volume":"34","author":"Araujo","year":"2015","journal-title":"Eur J Clin Microbiol Infect Dis."},{"key":"2022050616242319400_bib66","doi-asserted-by":"crossref","first-page":"e666","DOI":"10.1111\/j.1439-0507.2011.02032.x","article-title":"Emerging molds: epidemiological trends and antifungal resistance","volume":"54","author":"Miceli","year":"2011","journal-title":"Mycoses."},{"key":"2022050616242319400_bib67","first-page":"1917","article-title":"Rare fungal infectious agents: a lurking enemy","volume-title":"F1000Res.","author":"Skiada","year":"2017"},{"key":"2022050616242319400_bib68","doi-asserted-by":"crossref","first-page":"3823","DOI":"10.1128\/AAC.00636-13","article-title":"Multicenter study of isavuconazole MIC distributions and epidemiological cut-off values for Aspergillus spp. for the CLSI M38-A2 broth microdilution method","volume":"57","author":"Espinel-Ingroff","year":"2013","journal-title":"Antimicrob Agents Chemother."}],"container-title":["Medical Mycology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/mmy\/advance-article-pdf\/doi\/10.1093\/mmy\/myac028\/43518304\/myac028.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mmy\/article-pdf\/60\/5\/myac028\/43590773\/myac028.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mmy\/article-pdf\/60\/5\/myac028\/43590773\/myac028.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,6]],"date-time":"2022-05-06T16:28:28Z","timestamp":1651854508000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mmy\/article\/doi\/10.1093\/mmy\/myac028\/6576774"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":68,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5,6]]}},"URL":"https:\/\/doi.org\/10.1093\/mmy\/myac028","relation":{},"ISSN":["1369-3786","1460-2709"],"issn-type":[{"value":"1369-3786","type":"print"},{"value":"1460-2709","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,5]]},"published":{"date-parts":[[2022,5]]},"article-number":"myac028"}}